nodes	percent_of_prediction	percent_of_DWPC	metapath
Fospropofol—Hepatic insufficiency—Vinorelbine—ovarian cancer	0.1	0.14	CcSEcCtD
Fospropofol—Hypoxemia—Vinorelbine—ovarian cancer	0.0771	0.108	CcSEcCtD
Fospropofol—Propofol—CYP1B1—ovarian cancer	0.0474	1	CrCbGaD
Fospropofol—Hypoxia—Vinorelbine—ovarian cancer	0.0244	0.0342	CcSEcCtD
Fospropofol—Tingling sensation—Melphalan—ovarian cancer	0.022	0.0309	CcSEcCtD
Fospropofol—Vomiting—Altretamine—ovarian cancer	0.013	0.0182	CcSEcCtD
Fospropofol—Tingling sensation—Paclitaxel—ovarian cancer	0.0129	0.0182	CcSEcCtD
Fospropofol—Hepatic failure—Vinorelbine—ovarian cancer	0.0125	0.0175	CcSEcCtD
Fospropofol—Nausea—Altretamine—ovarian cancer	0.0121	0.017	CcSEcCtD
Fospropofol—Pain—Carboplatin—ovarian cancer	0.0121	0.0169	CcSEcCtD
Fospropofol—Ventricular tachycardia—Paclitaxel—ovarian cancer	0.0104	0.0146	CcSEcCtD
Fospropofol—Angiopathy—Topotecan—ovarian cancer	0.00824	0.0116	CcSEcCtD
Fospropofol—Mediastinal disorder—Topotecan—ovarian cancer	0.00819	0.0115	CcSEcCtD
Fospropofol—Mediastinal disorder—Melphalan—ovarian cancer	0.00802	0.0112	CcSEcCtD
Fospropofol—Stinging—Epirubicin—ovarian cancer	0.00735	0.0103	CcSEcCtD
Fospropofol—Hepatic failure—Docetaxel—ovarian cancer	0.00713	0.01	CcSEcCtD
Fospropofol—Angiopathy—Vinorelbine—ovarian cancer	0.00705	0.00989	CcSEcCtD
Fospropofol—Mediastinal disorder—Vinorelbine—ovarian cancer	0.007	0.00983	CcSEcCtD
Fospropofol—Cough—Topotecan—ovarian cancer	0.0069	0.00968	CcSEcCtD
Fospropofol—Stinging—Doxorubicin—ovarian cancer	0.0068	0.00954	CcSEcCtD
Fospropofol—Cough—Melphalan—ovarian cancer	0.00676	0.00948	CcSEcCtD
Fospropofol—Unspecified disorder of skin and subcutaneous tissue—Topotecan—ovarian cancer	0.00669	0.00938	CcSEcCtD
Fospropofol—Unspecified disorder of skin and subcutaneous tissue—Melphalan—ovarian cancer	0.00655	0.00919	CcSEcCtD
Fospropofol—Nervous system disorder—Topotecan—ovarian cancer	0.00633	0.00888	CcSEcCtD
Fospropofol—Skin disorder—Topotecan—ovarian cancer	0.00627	0.0088	CcSEcCtD
Fospropofol—Gastrointestinal disorder—Chlorambucil—ovarian cancer	0.00626	0.00878	CcSEcCtD
Fospropofol—Pain—Chlorambucil—ovarian cancer	0.0062	0.0087	CcSEcCtD
Fospropofol—Skin disorder—Melphalan—ovarian cancer	0.00614	0.00861	CcSEcCtD
Fospropofol—Ventricular tachycardia—Epirubicin—ovarian cancer	0.00595	0.00835	CcSEcCtD
Fospropofol—Hypotension—Melphalan—ovarian cancer	0.00591	0.00829	CcSEcCtD
Fospropofol—Cough—Vinorelbine—ovarian cancer	0.0059	0.00828	CcSEcCtD
Fospropofol—Paraesthesia—Topotecan—ovarian cancer	0.0058	0.00813	CcSEcCtD
Fospropofol—Unspecified disorder of skin and subcutaneous tissue—Vinorelbine—ovarian cancer	0.00572	0.00803	CcSEcCtD
Fospropofol—Paraesthesia—Melphalan—ovarian cancer	0.00567	0.00796	CcSEcCtD
Fospropofol—Gastrointestinal disorder—Topotecan—ovarian cancer	0.00557	0.00782	CcSEcCtD
Fospropofol—Pain—Topotecan—ovarian cancer	0.00552	0.00774	CcSEcCtD
Fospropofol—Ventricular tachycardia—Doxorubicin—ovarian cancer	0.00551	0.00773	CcSEcCtD
Fospropofol—Gastrointestinal disorder—Melphalan—ovarian cancer	0.00546	0.00766	CcSEcCtD
Fospropofol—Nervous system disorder—Vinorelbine—ovarian cancer	0.00541	0.0076	CcSEcCtD
Fospropofol—Pain—Melphalan—ovarian cancer	0.0054	0.00758	CcSEcCtD
Fospropofol—Skin disorder—Vinorelbine—ovarian cancer	0.00536	0.00752	CcSEcCtD
Fospropofol—Hypotension—Vinorelbine—ovarian cancer	0.00516	0.00724	CcSEcCtD
Fospropofol—Pruritus—Chlorambucil—ovarian cancer	0.00513	0.0072	CcSEcCtD
Fospropofol—Paraesthesia—Vinorelbine—ovarian cancer	0.00496	0.00696	CcSEcCtD
Fospropofol—Hepatic failure—Epirubicin—ovarian cancer	0.00481	0.00674	CcSEcCtD
Fospropofol—Gastrointestinal disorder—Vinorelbine—ovarian cancer	0.00477	0.00669	CcSEcCtD
Fospropofol—Angiopathy—Paclitaxel—ovarian cancer	0.00474	0.00665	CcSEcCtD
Fospropofol—Pain—Vinorelbine—ovarian cancer	0.00472	0.00662	CcSEcCtD
Fospropofol—Mediastinal disorder—Paclitaxel—ovarian cancer	0.00471	0.00661	CcSEcCtD
Fospropofol—Vomiting—Chlorambucil—ovarian cancer	0.00461	0.00647	CcSEcCtD
Fospropofol—Pruritus—Topotecan—ovarian cancer	0.00457	0.00641	CcSEcCtD
Fospropofol—Pruritus—Melphalan—ovarian cancer	0.00447	0.00627	CcSEcCtD
Fospropofol—Hepatic failure—Doxorubicin—ovarian cancer	0.00445	0.00624	CcSEcCtD
Fospropofol—Nausea—Chlorambucil—ovarian cancer	0.00431	0.00604	CcSEcCtD
Fospropofol—Vomiting—Topotecan—ovarian cancer	0.0041	0.00576	CcSEcCtD
Fospropofol—Headache—Topotecan—ovarian cancer	0.00404	0.00567	CcSEcCtD
Fospropofol—Angiopathy—Docetaxel—ovarian cancer	0.00402	0.00564	CcSEcCtD
Fospropofol—Vomiting—Melphalan—ovarian cancer	0.00402	0.00564	CcSEcCtD
Fospropofol—Mediastinal disorder—Docetaxel—ovarian cancer	0.00399	0.0056	CcSEcCtD
Fospropofol—Cough—Paclitaxel—ovarian cancer	0.00397	0.00557	CcSEcCtD
Fospropofol—Pruritus—Vinorelbine—ovarian cancer	0.00391	0.00548	CcSEcCtD
Fospropofol—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—ovarian cancer	0.00385	0.0054	CcSEcCtD
Fospropofol—Nausea—Topotecan—ovarian cancer	0.00383	0.00538	CcSEcCtD
Fospropofol—Nausea—Melphalan—ovarian cancer	0.00375	0.00527	CcSEcCtD
Fospropofol—Nervous system disorder—Paclitaxel—ovarian cancer	0.00364	0.00511	CcSEcCtD
Fospropofol—Skin disorder—Paclitaxel—ovarian cancer	0.00361	0.00506	CcSEcCtD
Fospropofol—Vomiting—Vinorelbine—ovarian cancer	0.00351	0.00493	CcSEcCtD
Fospropofol—Hypotension—Paclitaxel—ovarian cancer	0.00347	0.00487	CcSEcCtD
Fospropofol—Headache—Vinorelbine—ovarian cancer	0.00346	0.00485	CcSEcCtD
Fospropofol—Cough—Docetaxel—ovarian cancer	0.00337	0.00472	CcSEcCtD
Fospropofol—Paraesthesia—Paclitaxel—ovarian cancer	0.00333	0.00468	CcSEcCtD
Fospropofol—Nausea—Vinorelbine—ovarian cancer	0.00328	0.0046	CcSEcCtD
Fospropofol—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—ovarian cancer	0.00326	0.00458	CcSEcCtD
Fospropofol—Gastrointestinal disorder—Paclitaxel—ovarian cancer	0.00321	0.0045	CcSEcCtD
Fospropofol—Pain—Paclitaxel—ovarian cancer	0.00318	0.00446	CcSEcCtD
Fospropofol—Nervous system disorder—Docetaxel—ovarian cancer	0.00309	0.00433	CcSEcCtD
Fospropofol—Skin disorder—Docetaxel—ovarian cancer	0.00306	0.00429	CcSEcCtD
Fospropofol—Hypotension—Docetaxel—ovarian cancer	0.00294	0.00413	CcSEcCtD
Fospropofol—Paraesthesia—Docetaxel—ovarian cancer	0.00283	0.00397	CcSEcCtD
Fospropofol—Gastrointestinal disorder—Docetaxel—ovarian cancer	0.00272	0.00381	CcSEcCtD
Fospropofol—Angiopathy—Epirubicin—ovarian cancer	0.00271	0.0038	CcSEcCtD
Fospropofol—Mediastinal disorder—Epirubicin—ovarian cancer	0.00269	0.00378	CcSEcCtD
Fospropofol—Pain—Docetaxel—ovarian cancer	0.00269	0.00378	CcSEcCtD
Fospropofol—Pruritus—Paclitaxel—ovarian cancer	0.00263	0.00369	CcSEcCtD
Fospropofol—Angiopathy—Doxorubicin—ovarian cancer	0.00251	0.00352	CcSEcCtD
Fospropofol—Mediastinal disorder—Doxorubicin—ovarian cancer	0.00249	0.0035	CcSEcCtD
Fospropofol—Vomiting—Paclitaxel—ovarian cancer	0.00236	0.00331	CcSEcCtD
Fospropofol—Headache—Paclitaxel—ovarian cancer	0.00233	0.00326	CcSEcCtD
Fospropofol—Cough—Epirubicin—ovarian cancer	0.00227	0.00319	CcSEcCtD
Fospropofol—Pruritus—Docetaxel—ovarian cancer	0.00223	0.00312	CcSEcCtD
Fospropofol—Nausea—Paclitaxel—ovarian cancer	0.00221	0.0031	CcSEcCtD
Fospropofol—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—ovarian cancer	0.0022	0.00309	CcSEcCtD
Fospropofol—Cough—Doxorubicin—ovarian cancer	0.0021	0.00295	CcSEcCtD
Fospropofol—Nervous system disorder—Epirubicin—ovarian cancer	0.00208	0.00292	CcSEcCtD
Fospropofol—Skin disorder—Epirubicin—ovarian cancer	0.00206	0.00289	CcSEcCtD
Fospropofol—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—ovarian cancer	0.00204	0.00286	CcSEcCtD
Fospropofol—Vomiting—Docetaxel—ovarian cancer	0.002	0.00281	CcSEcCtD
Fospropofol—Hypotension—Epirubicin—ovarian cancer	0.00198	0.00278	CcSEcCtD
Fospropofol—Headache—Docetaxel—ovarian cancer	0.00197	0.00277	CcSEcCtD
Fospropofol—Nervous system disorder—Doxorubicin—ovarian cancer	0.00193	0.0027	CcSEcCtD
Fospropofol—Skin disorder—Doxorubicin—ovarian cancer	0.00191	0.00268	CcSEcCtD
Fospropofol—Paraesthesia—Epirubicin—ovarian cancer	0.00191	0.00267	CcSEcCtD
Fospropofol—Nausea—Docetaxel—ovarian cancer	0.00187	0.00262	CcSEcCtD
Fospropofol—Hypotension—Doxorubicin—ovarian cancer	0.00184	0.00258	CcSEcCtD
Fospropofol—Gastrointestinal disorder—Epirubicin—ovarian cancer	0.00183	0.00257	CcSEcCtD
Fospropofol—Pain—Epirubicin—ovarian cancer	0.00182	0.00255	CcSEcCtD
Fospropofol—Paraesthesia—Doxorubicin—ovarian cancer	0.00176	0.00248	CcSEcCtD
Fospropofol—Gastrointestinal disorder—Doxorubicin—ovarian cancer	0.0017	0.00238	CcSEcCtD
Fospropofol—Pain—Doxorubicin—ovarian cancer	0.00168	0.00236	CcSEcCtD
Fospropofol—Pruritus—Epirubicin—ovarian cancer	0.0015	0.00211	CcSEcCtD
Fospropofol—GABRB1—Neuronal System—NSF—ovarian cancer	0.00146	0.00609	CbGpPWpGaD
Fospropofol—ALPL—BDNF signaling pathway—STAT3—ovarian cancer	0.00145	0.00603	CbGpPWpGaD
Fospropofol—Pruritus—Doxorubicin—ovarian cancer	0.00139	0.00195	CcSEcCtD
Fospropofol—GABRA6—Neuronal System—NSF—ovarian cancer	0.00138	0.00576	CbGpPWpGaD
Fospropofol—ALPL—BDNF signaling pathway—MAPK3—ovarian cancer	0.00138	0.00576	CbGpPWpGaD
Fospropofol—ALB—Binding and Uptake of Ligands by Scavenger Receptors—SPARC—ovarian cancer	0.00138	0.00573	CbGpPWpGaD
Fospropofol—GABRA4—Neuronal System—NSF—ovarian cancer	0.00136	0.00569	CbGpPWpGaD
Fospropofol—Vomiting—Epirubicin—ovarian cancer	0.00135	0.00189	CcSEcCtD
Fospropofol—GABRA1—Ion channel transport—ATP7B—ovarian cancer	0.00134	0.00557	CbGpPWpGaD
Fospropofol—Headache—Epirubicin—ovarian cancer	0.00133	0.00187	CcSEcCtD
Fospropofol—ALPL—BDNF signaling pathway—MAPK1—ovarian cancer	0.00131	0.00548	CbGpPWpGaD
Fospropofol—GABRA1—Transmission across Chemical Synapses—NSF—ovarian cancer	0.0013	0.00543	CbGpPWpGaD
Fospropofol—Nausea—Epirubicin—ovarian cancer	0.00126	0.00177	CcSEcCtD
Fospropofol—Vomiting—Doxorubicin—ovarian cancer	0.00125	0.00175	CcSEcCtD
Fospropofol—GABRB2—Neuronal System—NSF—ovarian cancer	0.00125	0.0052	CbGpPWpGaD
Fospropofol—Headache—Doxorubicin—ovarian cancer	0.00123	0.00173	CcSEcCtD
Fospropofol—GABRA5—Neuronal System—NSF—ovarian cancer	0.00121	0.00505	CbGpPWpGaD
Fospropofol—GABRA3—Neuronal System—NSF—ovarian cancer	0.00119	0.00496	CbGpPWpGaD
Fospropofol—GABRA2—Neuronal System—NSF—ovarian cancer	0.00117	0.00488	CbGpPWpGaD
Fospropofol—Nausea—Doxorubicin—ovarian cancer	0.00117	0.00164	CcSEcCtD
Fospropofol—GABRB3—Neuronal System—NSF—ovarian cancer	0.00116	0.00485	CbGpPWpGaD
Fospropofol—GABRG2—Neuronal System—NSF—ovarian cancer	0.00114	0.00476	CbGpPWpGaD
Fospropofol—ALPL—BDNF signaling pathway—HRAS—ovarian cancer	0.00106	0.0044	CbGpPWpGaD
Fospropofol—GABRB3—BDNF signaling pathway—IKBKG—ovarian cancer	0.00105	0.00437	CbGpPWpGaD
Fospropofol—GABRA1—Neuronal System—NSF—ovarian cancer	0.000998	0.00416	CbGpPWpGaD
Fospropofol—ALPL—BDNF signaling pathway—AKT1—ovarian cancer	0.000932	0.00388	CbGpPWpGaD
Fospropofol—ALB—Vitamin B12 Metabolism—SOD1—ovarian cancer	0.00084	0.0035	CbGpPWpGaD
Fospropofol—ALB—Platelet degranulation—SPARC—ovarian cancer	0.000806	0.00336	CbGpPWpGaD
Fospropofol—ALB—Response to elevated platelet cytosolic Ca2+—SPARC—ovarian cancer	0.000768	0.0032	CbGpPWpGaD
Fospropofol—ALB—Vitamin B12 Metabolism—SOD2—ovarian cancer	0.000756	0.00315	CbGpPWpGaD
Fospropofol—GABRG3—Transmembrane transport of small molecules—AQP3—ovarian cancer	0.000721	0.00301	CbGpPWpGaD
Fospropofol—GABRB1—Transmembrane transport of small molecules—AQP3—ovarian cancer	0.00071	0.00296	CbGpPWpGaD
Fospropofol—GABRG3—Transmembrane transport of small molecules—ATP7B—ovarian cancer	0.000691	0.00288	CbGpPWpGaD
Fospropofol—ALB—Folate Metabolism—SOD1—ovarian cancer	0.000683	0.00285	CbGpPWpGaD
Fospropofol—GABRB1—Transmembrane transport of small molecules—ATP7B—ovarian cancer	0.000681	0.00284	CbGpPWpGaD
Fospropofol—GABRA6—Transmembrane transport of small molecules—AQP3—ovarian cancer	0.000672	0.0028	CbGpPWpGaD
Fospropofol—GABRA4—Transmembrane transport of small molecules—AQP3—ovarian cancer	0.000664	0.00277	CbGpPWpGaD
Fospropofol—GABRA6—Transmembrane transport of small molecules—ATP7B—ovarian cancer	0.000644	0.00269	CbGpPWpGaD
Fospropofol—GABRA4—Transmembrane transport of small molecules—ATP7B—ovarian cancer	0.000636	0.00265	CbGpPWpGaD
Fospropofol—ALB—Lipid and lipoprotein metabolism—CAV1—ovarian cancer	0.000624	0.0026	CbGpPWpGaD
Fospropofol—ALB—Folate Metabolism—SOD2—ovarian cancer	0.000615	0.00256	CbGpPWpGaD
Fospropofol—GABRB2—Transmembrane transport of small molecules—AQP3—ovarian cancer	0.000607	0.00253	CbGpPWpGaD
Fospropofol—GABRA5—Transmembrane transport of small molecules—AQP3—ovarian cancer	0.00059	0.00246	CbGpPWpGaD
Fospropofol—ALB—Platelet degranulation—SOD1—ovarian cancer	0.000586	0.00244	CbGpPWpGaD
Fospropofol—GABRB2—Transmembrane transport of small molecules—ATP7B—ovarian cancer	0.000582	0.00243	CbGpPWpGaD
Fospropofol—GABRA3—Transmembrane transport of small molecules—AQP3—ovarian cancer	0.000579	0.00241	CbGpPWpGaD
Fospropofol—GABRA2—Transmembrane transport of small molecules—AQP3—ovarian cancer	0.000569	0.00237	CbGpPWpGaD
Fospropofol—GABRA5—Transmembrane transport of small molecules—ATP7B—ovarian cancer	0.000565	0.00236	CbGpPWpGaD
Fospropofol—GABRB3—Transmembrane transport of small molecules—AQP3—ovarian cancer	0.000565	0.00236	CbGpPWpGaD
Fospropofol—ALB—Response to elevated platelet cytosolic Ca2+—SOD1—ovarian cancer	0.000558	0.00233	CbGpPWpGaD
Fospropofol—GABRG2—Transmembrane transport of small molecules—AQP3—ovarian cancer	0.000555	0.00231	CbGpPWpGaD
Fospropofol—GABRA3—Transmembrane transport of small molecules—ATP7B—ovarian cancer	0.000555	0.00231	CbGpPWpGaD
Fospropofol—GABRG3—Transmembrane transport of small molecules—TUBB3—ovarian cancer	0.000546	0.00228	CbGpPWpGaD
Fospropofol—GABRA2—Transmembrane transport of small molecules—ATP7B—ovarian cancer	0.000546	0.00227	CbGpPWpGaD
Fospropofol—ALB—Selenium Micronutrient Network—SOD1—ovarian cancer	0.000543	0.00226	CbGpPWpGaD
Fospropofol—GABRB3—Transmembrane transport of small molecules—ATP7B—ovarian cancer	0.000542	0.00226	CbGpPWpGaD
Fospropofol—GABRB1—Transmembrane transport of small molecules—TUBB3—ovarian cancer	0.000538	0.00224	CbGpPWpGaD
Fospropofol—GABRG2—Transmembrane transport of small molecules—ATP7B—ovarian cancer	0.000532	0.00222	CbGpPWpGaD
Fospropofol—GABRA6—Transmembrane transport of small molecules—TUBB3—ovarian cancer	0.000509	0.00212	CbGpPWpGaD
Fospropofol—GABRA4—Transmembrane transport of small molecules—TUBB3—ovarian cancer	0.000503	0.0021	CbGpPWpGaD
Fospropofol—GABRB3—BDNF signaling pathway—APC—ovarian cancer	0.000496	0.00207	CbGpPWpGaD
Fospropofol—ALB—Selenium Micronutrient Network—SOD2—ovarian cancer	0.000489	0.00204	CbGpPWpGaD
Fospropofol—GABRA1—Transmembrane transport of small molecules—AQP3—ovarian cancer	0.000485	0.00202	CbGpPWpGaD
Fospropofol—GABRA1—Transmembrane transport of small molecules—ATP7B—ovarian cancer	0.000465	0.00194	CbGpPWpGaD
Fospropofol—GABRB2—Transmembrane transport of small molecules—TUBB3—ovarian cancer	0.00046	0.00192	CbGpPWpGaD
Fospropofol—GABRA5—Transmembrane transport of small molecules—TUBB3—ovarian cancer	0.000447	0.00186	CbGpPWpGaD
Fospropofol—GABRA3—Transmembrane transport of small molecules—TUBB3—ovarian cancer	0.000439	0.00183	CbGpPWpGaD
Fospropofol—GABRA2—Transmembrane transport of small molecules—TUBB3—ovarian cancer	0.000431	0.0018	CbGpPWpGaD
Fospropofol—GABRB3—Transmembrane transport of small molecules—TUBB3—ovarian cancer	0.000428	0.00179	CbGpPWpGaD
Fospropofol—GABRG2—Transmembrane transport of small molecules—TUBB3—ovarian cancer	0.000421	0.00175	CbGpPWpGaD
Fospropofol—GABRB3—BDNF signaling pathway—MTOR—ovarian cancer	0.00038	0.00158	CbGpPWpGaD
Fospropofol—GABRA1—Transmembrane transport of small molecules—TUBB3—ovarian cancer	0.000368	0.00153	CbGpPWpGaD
Fospropofol—GABRG3—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	0.000365	0.00152	CbGpPWpGaD
Fospropofol—GABRB1—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	0.000359	0.0015	CbGpPWpGaD
Fospropofol—ALB—Platelet activation, signaling and aggregation—SPARC—ovarian cancer	0.000358	0.00149	CbGpPWpGaD
Fospropofol—GABRG3—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	0.000352	0.00147	CbGpPWpGaD
Fospropofol—GABRB3—BDNF signaling pathway—CASP3—ovarian cancer	0.00035	0.00146	CbGpPWpGaD
Fospropofol—GABRG3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—ovarian cancer	0.000348	0.00145	CbGpPWpGaD
Fospropofol—GABRB1—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	0.000347	0.00145	CbGpPWpGaD
Fospropofol—ALB—Hemostasis—RAD51C—ovarian cancer	0.000345	0.00144	CbGpPWpGaD
Fospropofol—GABRB1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—ovarian cancer	0.000343	0.00143	CbGpPWpGaD
Fospropofol—GABRA6—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	0.00034	0.00142	CbGpPWpGaD
Fospropofol—GABRB3—BDNF signaling pathway—CTNNB1—ovarian cancer	0.000337	0.0014	CbGpPWpGaD
Fospropofol—GABRA4—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	0.000336	0.0014	CbGpPWpGaD
Fospropofol—GABRA6—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	0.000328	0.00137	CbGpPWpGaD
Fospropofol—GABRA6—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—ovarian cancer	0.000325	0.00135	CbGpPWpGaD
Fospropofol—GABRA4—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	0.000324	0.00135	CbGpPWpGaD
Fospropofol—GABRA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—ovarian cancer	0.000321	0.00134	CbGpPWpGaD
Fospropofol—ALB—Folate Metabolism—IL2—ovarian cancer	0.00032	0.00133	CbGpPWpGaD
Fospropofol—GABRB2—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	0.000307	0.00128	CbGpPWpGaD
Fospropofol—GABRA5—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	0.000298	0.00124	CbGpPWpGaD
Fospropofol—GABRB2—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	0.000296	0.00124	CbGpPWpGaD
Fospropofol—GABRA1—SIDS Susceptibility Pathways—CXCL8—ovarian cancer	0.000294	0.00123	CbGpPWpGaD
Fospropofol—GABRB3—BDNF signaling pathway—STAT3—ovarian cancer	0.000294	0.00122	CbGpPWpGaD
Fospropofol—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—ovarian cancer	0.000293	0.00122	CbGpPWpGaD
Fospropofol—GABRA3—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	0.000293	0.00122	CbGpPWpGaD
Fospropofol—GABRA5—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	0.000288	0.0012	CbGpPWpGaD
Fospropofol—GABRA2—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	0.000288	0.0012	CbGpPWpGaD
Fospropofol—GABRB3—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	0.000286	0.00119	CbGpPWpGaD
Fospropofol—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—ovarian cancer	0.000285	0.00119	CbGpPWpGaD
Fospropofol—GABRA3—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	0.000283	0.00118	CbGpPWpGaD
Fospropofol—GABRA1—SIDS Susceptibility Pathways—CASP3—ovarian cancer	0.000281	0.00117	CbGpPWpGaD
Fospropofol—GABRG2—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	0.000281	0.00117	CbGpPWpGaD
Fospropofol—GABRB3—BDNF signaling pathway—MAPK3—ovarian cancer	0.000281	0.00117	CbGpPWpGaD
Fospropofol—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—ovarian cancer	0.00028	0.00117	CbGpPWpGaD
Fospropofol—GABRG3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—ovarian cancer	0.00028	0.00117	CbGpPWpGaD
Fospropofol—GABRG3—Transmembrane transport of small molecules—ABCB1—ovarian cancer	0.000278	0.00116	CbGpPWpGaD
Fospropofol—GABRA2—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	0.000278	0.00116	CbGpPWpGaD
Fospropofol—ALB—Transmembrane transport of small molecules—AQP3—ovarian cancer	0.000278	0.00116	CbGpPWpGaD
Fospropofol—ALB—SLC-mediated transmembrane transport—SLC5A5—ovarian cancer	0.000276	0.00115	CbGpPWpGaD
Fospropofol—GABRB3—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	0.000276	0.00115	CbGpPWpGaD
Fospropofol—GABRB1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—ovarian cancer	0.000275	0.00115	CbGpPWpGaD
Fospropofol—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—ovarian cancer	0.000275	0.00115	CbGpPWpGaD
Fospropofol—ALB—Metabolism of lipids and lipoproteins—PPP1CC—ovarian cancer	0.000275	0.00114	CbGpPWpGaD
Fospropofol—GABRB1—Transmembrane transport of small molecules—ABCB1—ovarian cancer	0.000274	0.00114	CbGpPWpGaD
Fospropofol—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—ovarian cancer	0.000273	0.00114	CbGpPWpGaD
Fospropofol—GABRA1—SIDS Susceptibility Pathways—CTNNB1—ovarian cancer	0.000271	0.00113	CbGpPWpGaD
Fospropofol—GABRG2—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	0.000271	0.00113	CbGpPWpGaD
Fospropofol—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—ovarian cancer	0.000268	0.00112	CbGpPWpGaD
Fospropofol—GABRB3—BDNF signaling pathway—MAPK1—ovarian cancer	0.000267	0.00111	CbGpPWpGaD
Fospropofol—ALB—SLC-mediated transmembrane transport—SLC2A1—ovarian cancer	0.000267	0.00111	CbGpPWpGaD
Fospropofol—ALB—Transmembrane transport of small molecules—ATP7B—ovarian cancer	0.000266	0.00111	CbGpPWpGaD
Fospropofol—GABRG3—Transmission across Chemical Synapses—MAPK1—ovarian cancer	0.000262	0.00109	CbGpPWpGaD
Fospropofol—GABRA6—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—ovarian cancer	0.000261	0.00109	CbGpPWpGaD
Fospropofol—ALB—Platelet activation, signaling and aggregation—SOD1—ovarian cancer	0.00026	0.00108	CbGpPWpGaD
Fospropofol—GABRA6—Transmembrane transport of small molecules—ABCB1—ovarian cancer	0.000259	0.00108	CbGpPWpGaD
Fospropofol—GABRB1—Transmission across Chemical Synapses—MAPK1—ovarian cancer	0.000258	0.00108	CbGpPWpGaD
Fospropofol—GABRA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—ovarian cancer	0.000257	0.00107	CbGpPWpGaD
Fospropofol—GABRA4—Transmembrane transport of small molecules—ABCB1—ovarian cancer	0.000256	0.00107	CbGpPWpGaD
Fospropofol—GABRA1—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	0.000245	0.00102	CbGpPWpGaD
Fospropofol—GABRA6—Transmission across Chemical Synapses—MAPK1—ovarian cancer	0.000244	0.00102	CbGpPWpGaD
Fospropofol—GABRA4—Transmission across Chemical Synapses—MAPK1—ovarian cancer	0.000241	0.001	CbGpPWpGaD
Fospropofol—ALB—FOXA2 and FOXA3 transcription factor networks—AKT1—ovarian cancer	0.00024	0.001	CbGpPWpGaD
Fospropofol—GABRA1—SIDS Susceptibility Pathways—VEGFA—ovarian cancer	0.000239	0.000995	CbGpPWpGaD
Fospropofol—GABRA1—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	0.000237	0.000988	CbGpPWpGaD
Fospropofol—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—ovarian cancer	0.000235	0.000981	CbGpPWpGaD
Fospropofol—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—ovarian cancer	0.000234	0.000977	CbGpPWpGaD
Fospropofol—GABRB2—Transmembrane transport of small molecules—ABCB1—ovarian cancer	0.000234	0.000975	CbGpPWpGaD
Fospropofol—ALB—Platelet degranulation—VEGFA—ovarian cancer	0.000233	0.000972	CbGpPWpGaD
Fospropofol—ALB—Vitamin B12 Metabolism—IL6—ovarian cancer	0.000231	0.000964	CbGpPWpGaD
Fospropofol—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—ovarian cancer	0.000229	0.000953	CbGpPWpGaD
Fospropofol—GABRA5—Transmembrane transport of small molecules—ABCB1—ovarian cancer	0.000227	0.000947	CbGpPWpGaD
Fospropofol—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—ovarian cancer	0.000225	0.000936	CbGpPWpGaD
Fospropofol—GABRA3—Transmembrane transport of small molecules—ABCB1—ovarian cancer	0.000223	0.00093	CbGpPWpGaD
Fospropofol—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—ovarian cancer	0.000222	0.000926	CbGpPWpGaD
Fospropofol—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—ovarian cancer	0.000221	0.00092	CbGpPWpGaD
Fospropofol—GABRB2—Transmission across Chemical Synapses—MAPK1—ovarian cancer	0.00022	0.000919	CbGpPWpGaD
Fospropofol—GABRA2—Transmembrane transport of small molecules—ABCB1—ovarian cancer	0.000219	0.000914	CbGpPWpGaD
Fospropofol—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—ovarian cancer	0.000219	0.000914	CbGpPWpGaD
Fospropofol—GABRB3—Transmembrane transport of small molecules—ABCB1—ovarian cancer	0.000218	0.000908	CbGpPWpGaD
Fospropofol—ALB—Metabolism—NME2—ovarian cancer	0.000217	0.000905	CbGpPWpGaD
Fospropofol—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—ovarian cancer	0.000215	0.000897	CbGpPWpGaD
Fospropofol—GABRB3—BDNF signaling pathway—HRAS—ovarian cancer	0.000214	0.000893	CbGpPWpGaD
Fospropofol—GABRA5—Transmission across Chemical Synapses—MAPK1—ovarian cancer	0.000214	0.000892	CbGpPWpGaD
Fospropofol—GABRG2—Transmembrane transport of small molecules—ABCB1—ovarian cancer	0.000214	0.000892	CbGpPWpGaD
Fospropofol—ALB—Transmembrane transport of small molecules—TUBB3—ovarian cancer	0.000211	0.000877	CbGpPWpGaD
Fospropofol—GABRA3—Transmission across Chemical Synapses—MAPK1—ovarian cancer	0.00021	0.000876	CbGpPWpGaD
Fospropofol—GABRG3—Transmission across Chemical Synapses—HRAS—ovarian cancer	0.00021	0.000876	CbGpPWpGaD
Fospropofol—GABRB1—Transmission across Chemical Synapses—HRAS—ovarian cancer	0.000207	0.000863	CbGpPWpGaD
Fospropofol—GABRA2—Transmission across Chemical Synapses—MAPK1—ovarian cancer	0.000207	0.000861	CbGpPWpGaD
Fospropofol—ALB—Folate Metabolism—TP53—ovarian cancer	0.000206	0.000857	CbGpPWpGaD
Fospropofol—GABRB3—Transmission across Chemical Synapses—MAPK1—ovarian cancer	0.000205	0.000856	CbGpPWpGaD
Fospropofol—GABRG2—Transmission across Chemical Synapses—MAPK1—ovarian cancer	0.000202	0.00084	CbGpPWpGaD
Fospropofol—GABRG3—Neuronal System—MAPK1—ovarian cancer	0.000201	0.000836	CbGpPWpGaD
Fospropofol—GABRB1—Neuronal System—MAPK1—ovarian cancer	0.000198	0.000824	CbGpPWpGaD
Fospropofol—GABRA6—Transmission across Chemical Synapses—HRAS—ovarian cancer	0.000196	0.000817	CbGpPWpGaD
Fospropofol—GABRA4—Transmission across Chemical Synapses—HRAS—ovarian cancer	0.000193	0.000806	CbGpPWpGaD
Fospropofol—GABRB3—BDNF signaling pathway—AKT1—ovarian cancer	0.000189	0.000789	CbGpPWpGaD
Fospropofol—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—ovarian cancer	0.000188	0.000784	CbGpPWpGaD
Fospropofol—ALB—Folate Metabolism—IL6—ovarian cancer	0.000188	0.000784	CbGpPWpGaD
Fospropofol—GABRA1—Transmembrane transport of small molecules—ABCB1—ovarian cancer	0.000187	0.00078	CbGpPWpGaD
Fospropofol—GABRA6—Neuronal System—MAPK1—ovarian cancer	0.000187	0.000779	CbGpPWpGaD
Fospropofol—GABRA4—Neuronal System—MAPK1—ovarian cancer	0.000185	0.00077	CbGpPWpGaD
Fospropofol—ALB—Hemostasis—SPARC—ovarian cancer	0.000184	0.000768	CbGpPWpGaD
Fospropofol—ALB—Metabolism of lipids and lipoproteins—YAP1—ovarian cancer	0.000184	0.000768	CbGpPWpGaD
Fospropofol—GABRB2—Transmission across Chemical Synapses—HRAS—ovarian cancer	0.000177	0.000738	CbGpPWpGaD
Fospropofol—GABRA1—Transmission across Chemical Synapses—MAPK1—ovarian cancer	0.000176	0.000734	CbGpPWpGaD
Fospropofol—ALB—Platelet activation, signaling and aggregation—PIK3CG—ovarian cancer	0.000173	0.000721	CbGpPWpGaD
Fospropofol—GABRA5—Transmission across Chemical Synapses—HRAS—ovarian cancer	0.000172	0.000717	CbGpPWpGaD
Fospropofol—GABRB2—Neuronal System—MAPK1—ovarian cancer	0.000169	0.000704	CbGpPWpGaD
Fospropofol—GABRA3—Transmission across Chemical Synapses—HRAS—ovarian cancer	0.000169	0.000704	CbGpPWpGaD
Fospropofol—GABRA2—Transmission across Chemical Synapses—HRAS—ovarian cancer	0.000166	0.000691	CbGpPWpGaD
Fospropofol—GABRA1—SIDS Susceptibility Pathways—IL6—ovarian cancer	0.000165	0.000688	CbGpPWpGaD
Fospropofol—GABRB3—Transmission across Chemical Synapses—HRAS—ovarian cancer	0.000165	0.000687	CbGpPWpGaD
Fospropofol—GABRA5—Neuronal System—MAPK1—ovarian cancer	0.000164	0.000684	CbGpPWpGaD
Fospropofol—GABRG2—Transmission across Chemical Synapses—HRAS—ovarian cancer	0.000162	0.000675	CbGpPWpGaD
Fospropofol—GABRA3—Neuronal System—MAPK1—ovarian cancer	0.000161	0.000671	CbGpPWpGaD
Fospropofol—GABRG3—Neuronal System—HRAS—ovarian cancer	0.000161	0.000671	CbGpPWpGaD
Fospropofol—GABRB1—Neuronal System—HRAS—ovarian cancer	0.000159	0.000661	CbGpPWpGaD
Fospropofol—GABRA2—Neuronal System—MAPK1—ovarian cancer	0.000158	0.00066	CbGpPWpGaD
Fospropofol—GABRB3—Neuronal System—MAPK1—ovarian cancer	0.000157	0.000656	CbGpPWpGaD
Fospropofol—GABRG2—Neuronal System—MAPK1—ovarian cancer	0.000154	0.000644	CbGpPWpGaD
Fospropofol—ALB—Platelet activation, signaling and aggregation—PIK3CD—ovarian cancer	0.000152	0.000634	CbGpPWpGaD
Fospropofol—ALB—Metabolism of lipids and lipoproteins—FASN—ovarian cancer	0.00015	0.000626	CbGpPWpGaD
Fospropofol—GABRA6—Neuronal System—HRAS—ovarian cancer	0.00015	0.000626	CbGpPWpGaD
Fospropofol—ALB—Selenium Micronutrient Network—IL6—ovarian cancer	0.000149	0.000623	CbGpPWpGaD
Fospropofol—GABRA4—Neuronal System—HRAS—ovarian cancer	0.000148	0.000618	CbGpPWpGaD
Fospropofol—GABRA1—Transmission across Chemical Synapses—HRAS—ovarian cancer	0.000141	0.00059	CbGpPWpGaD
Fospropofol—ALB—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	0.00014	0.000585	CbGpPWpGaD
Fospropofol—ALB—Metabolism—CYTB—ovarian cancer	0.00014	0.000583	CbGpPWpGaD
Fospropofol—ALB—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	0.000137	0.00057	CbGpPWpGaD
Fospropofol—ALB—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	0.000136	0.000565	CbGpPWpGaD
Fospropofol—GABRB2—Neuronal System—HRAS—ovarian cancer	0.000136	0.000565	CbGpPWpGaD
Fospropofol—GABRA1—Neuronal System—MAPK1—ovarian cancer	0.000135	0.000563	CbGpPWpGaD
Fospropofol—ALB—Hemostasis—SOD1—ovarian cancer	0.000134	0.000558	CbGpPWpGaD
Fospropofol—ALB—Hemostasis—PPP2R1A—ovarian cancer	0.000133	0.000555	CbGpPWpGaD
Fospropofol—ALB—Platelet activation, signaling and aggregation—PIK3CB—ovarian cancer	0.000133	0.000553	CbGpPWpGaD
Fospropofol—GABRA5—Neuronal System—HRAS—ovarian cancer	0.000132	0.000549	CbGpPWpGaD
Fospropofol—GABRA3—Neuronal System—HRAS—ovarian cancer	0.000129	0.000539	CbGpPWpGaD
Fospropofol—GABRA2—Neuronal System—HRAS—ovarian cancer	0.000127	0.00053	CbGpPWpGaD
Fospropofol—GABRB3—Neuronal System—HRAS—ovarian cancer	0.000126	0.000526	CbGpPWpGaD
Fospropofol—GABRG2—Neuronal System—HRAS—ovarian cancer	0.000124	0.000517	CbGpPWpGaD
Fospropofol—ALB—Metabolism—BRIP1—ovarian cancer	0.000122	0.00051	CbGpPWpGaD
Fospropofol—ALB—Metabolism—PPP1CC—ovarian cancer	0.000122	0.00051	CbGpPWpGaD
Fospropofol—ALB—Platelet activation, signaling and aggregation—IL2—ovarian cancer	0.000122	0.000507	CbGpPWpGaD
Fospropofol—GABRA1—Neuronal System—HRAS—ovarian cancer	0.000108	0.000452	CbGpPWpGaD
Fospropofol—ALB—Transmembrane transport of small molecules—ABCB1—ovarian cancer	0.000107	0.000446	CbGpPWpGaD
Fospropofol—ALB—Platelet activation, signaling and aggregation—VEGFA—ovarian cancer	0.000103	0.000431	CbGpPWpGaD
Fospropofol—ALB—Hemostasis—CAV1—ovarian cancer	9.79e-05	0.000408	CbGpPWpGaD
Fospropofol—ALB—Platelet activation, signaling and aggregation—MAPK3—ovarian cancer	9.79e-05	0.000408	CbGpPWpGaD
Fospropofol—ALB—Platelet activation, signaling and aggregation—MAPK1—ovarian cancer	9.31e-05	0.000388	CbGpPWpGaD
Fospropofol—ALB—Hemostasis—PIK3CG—ovarian cancer	8.92e-05	0.000372	CbGpPWpGaD
Fospropofol—ALB—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	8.91e-05	0.000371	CbGpPWpGaD
Fospropofol—ALB—Metabolism—YAP1—ovarian cancer	8.2e-05	0.000342	CbGpPWpGaD
Fospropofol—ALB—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	8.12e-05	0.000338	CbGpPWpGaD
Fospropofol—ALB—Platelet activation, signaling and aggregation—PIK3CA—ovarian cancer	8.08e-05	0.000337	CbGpPWpGaD
Fospropofol—ALB—Hemostasis—PIK3CD—ovarian cancer	7.84e-05	0.000327	CbGpPWpGaD
Fospropofol—ALB—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	7.14e-05	0.000297	CbGpPWpGaD
Fospropofol—ALB—Hemostasis—PIK3CB—ovarian cancer	6.83e-05	0.000285	CbGpPWpGaD
Fospropofol—ALB—Metabolism—FASN—ovarian cancer	6.69e-05	0.000279	CbGpPWpGaD
Fospropofol—ALB—Platelet activation, signaling and aggregation—AKT1—ovarian cancer	6.6e-05	0.000275	CbGpPWpGaD
Fospropofol—ALB—Metabolism—SLC5A5—ovarian cancer	6.58e-05	0.000274	CbGpPWpGaD
Fospropofol—ALB—Metabolism—SLC2A1—ovarian cancer	6.35e-05	0.000265	CbGpPWpGaD
Fospropofol—ALB—Hemostasis—IL2—ovarian cancer	6.28e-05	0.000262	CbGpPWpGaD
Fospropofol—ALB—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	6.22e-05	0.000259	CbGpPWpGaD
Fospropofol—ALB—Metabolism—CYP1B1—ovarian cancer	6.09e-05	0.000254	CbGpPWpGaD
Fospropofol—ALB—Metabolism—PPP2R1A—ovarian cancer	5.4e-05	0.000225	CbGpPWpGaD
Fospropofol—ALB—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	5.38e-05	0.000224	CbGpPWpGaD
Fospropofol—ALB—Hemostasis—VEGFA—ovarian cancer	5.33e-05	0.000222	CbGpPWpGaD
Fospropofol—ALB—Hemostasis—NRAS—ovarian cancer	5.27e-05	0.00022	CbGpPWpGaD
Fospropofol—ALB—Hemostasis—MAPK3—ovarian cancer	5.05e-05	0.00021	CbGpPWpGaD
Fospropofol—ALB—Metabolism—ABCB1—ovarian cancer	5.02e-05	0.000209	CbGpPWpGaD
Fospropofol—ALB—Metabolism—TYMS—ovarian cancer	4.93e-05	0.000205	CbGpPWpGaD
Fospropofol—ALB—Hemostasis—MAPK1—ovarian cancer	4.8e-05	0.0002	CbGpPWpGaD
Fospropofol—ALB—Hemostasis—KRAS—ovarian cancer	4.53e-05	0.000189	CbGpPWpGaD
Fospropofol—ALB—Hemostasis—PIK3CA—ovarian cancer	4.17e-05	0.000174	CbGpPWpGaD
Fospropofol—ALB—Hemostasis—TP53—ovarian cancer	4.03e-05	0.000168	CbGpPWpGaD
Fospropofol—ALB—Metabolism—CAV1—ovarian cancer	3.97e-05	0.000165	CbGpPWpGaD
Fospropofol—ALB—Hemostasis—HRAS—ovarian cancer	3.85e-05	0.000161	CbGpPWpGaD
Fospropofol—ALB—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	3.79e-05	0.000158	CbGpPWpGaD
Fospropofol—ALB—Metabolism—PIK3CG—ovarian cancer	3.62e-05	0.000151	CbGpPWpGaD
Fospropofol—ALB—Hemostasis—AKT1—ovarian cancer	3.4e-05	0.000142	CbGpPWpGaD
Fospropofol—ALB—Metabolism—PIK3CD—ovarian cancer	3.18e-05	0.000132	CbGpPWpGaD
Fospropofol—ALB—Metabolism—PIK3CB—ovarian cancer	2.77e-05	0.000115	CbGpPWpGaD
Fospropofol—ALB—Metabolism—PTEN—ovarian cancer	2.39e-05	9.98e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism—PIK3CA—ovarian cancer	1.69e-05	7.04e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism—AKT1—ovarian cancer	1.38e-05	5.75e-05	CbGpPWpGaD
